Neurodegenerative Diseases: Neurotoxins as Sufficient Etiologic Agents?
- 6 November 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in NeuroMolecular Medicine
- Vol. 10 (1), 1-9
- https://doi.org/10.1007/s12017-007-8016-8
Abstract
A dominant paradigm in neurological disease research is that the primary etiological factors for diseases such as Alzheimer’s (AD), Parkinson’s (PD), and amyotrophic lateral sclerosis (ALS) are genetic. Opposed to this perspective are the clear observations from epidemiology that purely genetic casual factors account for a relatively small fraction of all cases. Many who support a genetic etiology for neurological disease take the view that while the percentages may be relatively small, these numbers will rise in the future with the inevitable discoveries of additional genetic mutations. The follow up argument is that even if the last is not true, the events triggered by the aberrant genes identified so far will be shown to impact the same neuronal cell death pathways as those activated by environmental factors that trigger most sporadic disease cases. In this article we present a countervailing view that environmental neurotoxins may be the sole sufficient factor in at least three neurological disease clusters. For each, neurotoxins have been isolated and characterized that, at least in animal models, faithfully reproduce each disorder without the need for genetic co-factors. Based on these data, we will propose a set of principles that would enable any potential toxin to be evaluated as an etiological factor in a given neurodegenerative disease. Finally, we will attempt to put environmental toxins into the context of possible genetically-determined susceptibility.Keywords
This publication has 81 references indexed in Scilit:
- Chronic Exposure to Dietary Sterol Glucosides is Neurotoxic to Motor Neurons and Induces an ALS–PDC PhenotypeNeuroMolecular Medicine, 2008
- Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of GuamNeurology, 2007
- Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?Brain, 2007
- BMAA selectively injures motor neurons via AMPA/kainate receptor activationExperimental Neurology, 2006
- Als2 -deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalitiesProceedings of the National Academy of Sciences of the United States of America, 2006
- Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and MisassembledJournal of Neuroscience, 2006
- Further Evidence for Mitochondrial Dysfunction in Progressive Supranuclear PalsyExperimental Neurology, 2001
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineLife Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983